Navigation Links
Routine evaluation of prostate size not as effective in cancer screening, Mayo study finds
Date:11/10/2009

ROCHESTER, Minn. -- New Mayo Clinic research studied the association between prostate-specific antigen (PSA) levels and prostate size and found that routine annual evaluation of prostate growth is not necessarily a predictor for the development of prostate cancer. However the study suggests that if a man's PSA level is rising quickly, a prostate biopsy is reasonable to determine if he has prostate cancer. These findings are being presented this week at the North Central Section of the American Urological Association (http://www.ncsaua.org/) in Scottsdale, Ariz.

VIDEO ALERT: Additional audio and video resources are available on the Mayo Clinic News Blog (http://newsblog.mayoclinic.org/2009/11/09/routine-prostate-size-evaluation-not-as-effective-in-cancer-screening/).

These Mayo Clinic study findings were based on data in the Olmsted County Study of Urinary Health Status among Men, a large cohort study of men living in Olmsted County, Minn. Researchers randomly selected 616 men between the ages of 40 and 79 who did not have prostate disease. Patients participated in examinations every two years for 17 years, which included PSA and prostate volume measurements using ultrasound, to determine changes in prostate disease.

"One of the major advantages of this large cohort study is that the men have participated in this study for over 17 years," says Rodney Breau, M.D., a Mayo Clinic urologic oncology fellow who led the study. Because of this, we have the ability to look at long-term relationships between prostate growth, change in PSA and development of prostate cancer."

Of the 616 men, 58 (9.4 percent) developed prostate cancer. Men who were diagnosed with prostate cancer had a faster rise in PSA levels (6 percent/year) compared to men who were not diagnosed with cancer (3.3 percent/year). However, the increase in prostate size was similar between these two groups (median change of 2.2 percent/year).

PSA is a substance produced in the prostate gland. Normally, a small amount of PSA enters the bloodstream. A higher amount of PSA or an abrupt rise in PSA levels can indicate a problem, possibly cancer.

"The question we're trying to answer is, if we see a man with a rising PSA level, could this change in PSA be explained by a proportional increase in prostate size?" says Dr. Breau. "Our data indicate that men with or without prostate cancer have similar rates of prostate growth. If a man's PSA is quickly rising, he likely deserves a prostate biopsy to determine if he has prostate cancer. Assessment of change in prostate size should not influence the decision to biopsy."


'/>"/>

Contact: Amy Tieder
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. CDC Panel Says No to Routine Use of Gardasil for Boys
2. Study questions need for routine intervention in patients with renovascular disease
3. National Health Care Reformers Should Pay Attention to Lawsuit Alleging that Nations Largest Insurer Routinely Denies Liver Transplants
4. Back to School Season is Time for New Green Routines
5. Routine Testing Would Improve Herceptin Use in Breast Cancer
6. Make Eye Exams Part of the Back to School Routine
7. Dr. Donnica Moore Advocates that Women Follow a Preventive Dental Health Routine that Includes Crest Pro-Health Enamel Shield
8. On HIV Testing Day, HIVMA calls for health care reform to make testing routine every day
9. Kay Renz PR to Workout Publicity Routine for Adriana Martin, Founder of Fit Mom For Life
10. Hispanics Placing Their Oral Health at Risk by Cutting Back on Routine Dental Care
11. Institution of a bedtime routine improves sleep in infants and toddlers, maternal mood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/26/2017)... ... 26, 2017 , ... Founded as an independent institute in 1968, The ... special education. In 2018, Glenholme will celebrate its first 50 years and set ... farm for Hackney show ponies, was generously donated by Jean White Van Sinderen to ...
(Date:9/26/2017)... , ... September 26, 2017 , ... ... are collaborating on strategic and tactical plans for Pittcon 2018. As of July ... as president along with his named vice president, Charles Gardner, (ChemImage Corporation) and ...
(Date:9/26/2017)... ... ... “Childhood Memories of a Virginia Wanderer”: an entertaining look inside the author’s ... youth. “Childhood Memories of a Virginia Wanderer” is the creation of published author, Dewey ... He received his BS from Idaho State University in Adult Education, as well as ...
(Date:9/26/2017)... ... September 26, 2017 , ... Time out for Daddy is ... boy's newfound understanding that even grownups make mistakes. “Time Out for Daddy” is the ... for her entire life and whose passion for children inspired her to write this ...
(Date:9/25/2017)... ... ... The Renal Support Network (RSN) is proud to announce the launch of our ... on RSN’s mission to empower people who have kidney disease to become knowledgeable about ... unique website is loaded with hundreds of exclusive personal stories. These posts are written ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
(Date:9/5/2017)... 18 months after its February 2016 launch, market access ... of three new senior people to its rapidly expanding ... and James Wright bring decades of specialist ... Tammy Wynne joins as Director, Value Communication, ... over ten years, experience in global market access consultancy ...
(Date:9/1/2017)... 2017  Bayer will present the latest research from across ... Oncology (ESMO) 2017 Congress, September 8-12 in Madrid, ... and clinical data on Bayer,s marketed portfolio and late-stage compounds ... "We value the opportunity ... research at ESMO," said Carsten Brunn , Head of ...
Breaking Medicine Technology: